Open Door Day
This year, in addition to three outstanding Congress days, we are introducing an Open Door Day on 7 September 2021.
For one day only, we will give a sneak preview of the EMAS Congress. This day is free for anyone to attend and a great opportunity to experience a wide range of Society topics and learn from top industries in the field of menopause, andropause and healthy ageing.
In this new format, we are supported this year by our partner societies from Argentina, Russia and China. In order to raise awareness of these relevant issues among their members and to reach beyond the borders of Europe, we have decided to translate the entire first day into Spanish, Portuguese, Russian and Chinese (Mandarin).
Please note: There is no CME accreditation for the Open Door Day.
All times in CEST = Central Europe Summer Time. Please check the corresponding international time zones here.
Spread the word about our OPEN DOOR DAY – EMAS information and programme of the Open Door Day for download
On the occasion of the 2021 World Menopause & Work Day – A comprehensive summary of what menopause is all about and how it can affect people at work by EMAS Scientific Director Irene Lambrinoudaki and Rachel Weiss, the initiator of the Menopause Café charity. Amanda Griffiths from the University of Nottingham’s School of Medicine will collect questions from the audience to close with Q&A.
Please note: This session will be translated into Russian, Chinese (Mandarin), Portuguese and Spanish.
Programme at a glance:
Chair: Amanda Griffiths (UK)
Speakers:
Irene Lambrinoudaki (Greece)
Rachel Weiss (UK)
Q&A
More information: https://www.emas-online.org/emas-and-menopause-in-the-workplace-2021/
On the occasion of the 2021 World Menopause & Work Day – Claire Hardy will welcome Kathleen Riach and Rachel Suff to discuss what employers and managers should know about menopause in the workplace, including a practical experience-sharing presentation.
Programme at a glance:
Chair: Claire Hardy (UK)
Speakers:
Kathleen Riach (Australia)
Rachel Suff (UK)
Q&A
More information: https://www.emas-online.org/emas-and-menopause-in-the-workplace-2021/
On the occasion of the 2021 World Menopause & Work Day – In this session, moderated by EMAS President Antonio Cano, Margaret Rees will explain how some gynaecologists and general practitioners lack knowledge about the effect of menopause and its symptoms on the ability to work. Next, Emma Persand will discuss the cultural impact of menopause and warn of the need for a change in the way clinical consultations are oriented.
Programme at a glance:
Chair: Antonio Cano (Spain)
Speakers:
Margaret Rees (UK)
Emma Persand (UK)
Q&A
More information: https://www.emas-online.org/emas-and-menopause-in-the-workplace-2021/
This session is about new clinical research on early menopause and menopause. The Chairpersons Xiangyan Ruan and Alfred Mueck, with the speaker Muqing Gu, will discuss the prevention of Iatrogenic POI by Ovarian Tissue Cryopreservation and Transplantation. Rui Ju will explain sexual dysfunction in perimenopausal and postmenopausal women in China. In the same session, Xiangyan Ruan asks the following question: Can PGRMC1 be developed as a breast cancer risk marker? And Xin Yang gives insights into the management of premature ovarian failure after hematopoietic stem-cell transplantation for hematologic diseases.
Supported by: https://www.isgesociety.com/
Join us as Antonina Smetnik, Vice-President of the Russian Menopause Society and Head of the Department of Gynaecological Endocrinology, shares more about sex steroids, breast and breast cancer. Together with her colleagues Vera Balan and Elena Ermakova, she will discuss age, anti-age and ageism and the Management of vulvar lichen sclerosus.
Supported by: https://www.menopause-russia.org/
Learn more about how to get your paper published in Maturitas, the official journal of EMAS, I.F. 4.43. This session will present the essentials of how to write your paper, how to comply with publication ethics, the handling process and the quality assessment of papers in Maturitas.
Chairs: Irene Lambrinoudaki, Leon Flicker
Dimitrios Goulis: How to write a paper
Margaret Rees: Publications ethics
Irene Lambrinoudaki: What editors look at: Maturitas, Gynecology / Endocrinology
Leon Flicker: What editors look at: Maturitas, Aging / Care of older people
.
Supported by: https://www.elsevier.com/de-de
Join the highlights of the “EMAS Cancer School” to hear EMAS president Antonio Cano and Professor María Isabel Acién reviewing the size of the problem, inductors of early menopause in female cancer, the clinical impact and some cases.
This session is kindly supported by Italfarmaco.
More information: https://www.emas-online.org/
Be part of the ABBOTT Panel Discussion on MHT Safety – The Role of Progestogens in Menopause Treatment: With specialists like Tommaso Simoncini, Serge Rozenberg and Antonina Smetnik, moderated by Irene Lambrinoudaki and Juan Enrique Blumel.
Please note: This session will be translated into Russian, Chinese (Mandarin), Portuguese and Spanish.
Your active participation is desired. We invite you to send us your questions relevant to the topic in advance: [email protected]
Programme at a glance:
Chair: Irene Lambrinoudaki (Greece) & Juan Blumel (Chile)
Speakers:
Tommaso Simoncini (Italy) – Progestogens in MHT: effect on glucose and lipid metabolism
Serge Rozenberg (Belgium) – Progestogens in MHT and the risk of thrombosis
Antonina Smetnik (Russia) – Progestogens in MHT and the risk of breast cancer
Supported by: https://www.abbott.com/
Learn more about the Highlights of the “Late Parenthood” EMAS School. Hear the exchange on context, consequences and treatments of Dimitrios G. Goulis and Efstratios M. Kolibianakis. They give background information on current data and cases and their statements as endocrinologist and gynaecologist, specialized in assisted reproduction. Followed by an interactive discussion.
More information: https://www.emas-online.org/
The aim of this symposium is to carry out a quick and practical review on frequent and important aspects that affect climacteric women, such as cycle alterations, regarding abnormal uterine bleeding, cardiovascular disease, urogenital atrophy in healthy climacteric women, as in breast cancer survivors.
Supported by: http://aapec.org/
Angelica Lindén Hirschberg and Dimitrios G. Goulis will present two position statements and two clinical guides to be discussed afterwards in a 30-minute Q&A session with the audience.
More information: https://www.emas-online.org/
Be sure to join this session to get a general overview of Menopause from Gynecological Endocrinology. SAEGRE President Fabian Gomez Giglio and his guests Natalio Kuperman, Blanca Campostrini, Sandra Demayo, and Karina Sternberg will explore topics such as the Chances of Success of Fertility Treatments beyond the Age of 40, or Which is the most suitable Progestogen for HMT, and The Role of the Stress in Menopause as well as The Effect of Hormone Therapy and Cardiometabolic Risk in Postmenopausal Women.
Supported by: http://saegre.org.ar/
